Oral Administration of the Broad-Spectrum Antibiofilm Compound Toremifene Inhibits Candida albicansand Staphylococcus aureusBiofilm Formation In Vivo

MLA

De Cremer, Kaat, et al. “Oral Administration of the Broad-Spectrum Antibiofilm Compound Toremifene Inhibits Candida Albicansand Staphylococcus AureusBiofilm Formation In Vivo.” Antimicrobial Agents and Chemotherapy, vol. 58, no. 12, Sept. 2014, pp. 7606–10. EBSCOhost, https://doi.org/10.1128/AAC.03869-14.

APA

De Cremer, K., Delattin, N., De Brucker, K., Peeters, A., Kucharíková, S., Gerits, E., Verstraeten, N., Michiels, J., Van Dijck, P., Cammue, B. P. A., & Thevissen, K. (2014). Oral Administration of the Broad-Spectrum Antibiofilm Compound Toremifene Inhibits Candida albicansand Staphylococcus aureusBiofilm Formation In Vivo. Antimicrobial Agents and Chemotherapy, 58(12), 7606–7610. https://doi.org/10.1128/AAC.03869-14

Chicago

De Cremer, Kaat, Nicolas Delattin, Katrijn De Brucker, Annelies Peeters, Soña Kucharíková, Evelien Gerits, Natalie Verstraeten, et al. 2014. “Oral Administration of the Broad-Spectrum Antibiofilm Compound Toremifene Inhibits Candida Albicansand Staphylococcus AureusBiofilm Formation In Vivo.” Antimicrobial Agents and Chemotherapy 58 (12): 7606–10. doi:10.1128/AAC.03869-14.